|Ms. Alison Perry Bauerlein||Co-Founder, Exec. VP of Fin., CFO, Corp. Sec. & Corp. Treasurer||373.49k||204.88k||1981|
|Mr. Bart Sanford||Exec. VP of Operations||330.75k||N/A||1966|
|Mr. Nabil Shabshab||CEO, Pres & Director||N/A||N/A||1965|
|Mr. Brenton Taylor||Co-Founder & Exec. VP of Engineering||N/A||N/A||1981|
|Mr. Matthew James Bacso C.F.A., CFA||Investor Relations & Corp. Devel. Mang.||N/A||N/A||N/A|
|Mr. George J. Parr||Exec. VP & Chief Commercial Officer||N/A||N/A||1971|
|Mr. Matthew Pigeon||Investor Relations Officer||N/A||N/A||N/A|
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Inogen, Inc.’s ISS Governance QualityScore as of June 1, 2021 is 8. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 8; Compensation: 5.